Increasing bioavailability of magnesium ions by co-administration of vitamin K, allowing reduction of dosage in the treatment of magnesium deficiency syndrome

摘要

Increasing the bioavailability of magnesium ions in an organism involves administration of vitamin K (I). An Independent claim is included for a pharmaceutical packaging unit comprising: (i) magnesium ions, preferably formulated in granular form; (ii) vitamin K, preferably formulated in aqueous emulsion; and (iii) instruction for dosing.